Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.
Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.
SARS-CoV-2 Inactivated Vaccine (Vero cells) developed by Beijing Sinovac Biotech Co., Ltd was approved for marketing with conditions.
In order to promote the improvement of the technology and ensure the quality of medical laboratory testing, Shanghai Clinical Laboratory Center invited 10 hospitals to participate in the multi institute performance evaluation and validation
Sansure Biotech enters the pet market, pet medical is expected to become the company's new growth pole.
On January 30, 2021, Amoy Diagnostics and AstraZeneca signed a strategic cooperation on HRD testing and companion diagnosis for ovarian cancer.
The Hurun Research Institute released the 2020 Hurun Global 500 recently, a list of the 500 most valuable non-state-controlled companies in the world.
The Hurun Research Institute released the 2020 Hurun Global 500 recently, a list of the 500 most valuable non-state-controlled companies in the world.
Do I need to be vaccinated against COVID-19?
Due to January 18, a number of companies in the biomedical sector have issued performance forecasts.
Find out what is going on in Chinese in vitro diagnostic industry
Sansure Biotech released an announcement of performance increase on January 18, and it is expected that the net profit attributable to the owners of the parent company will be realized from 2.556 billion yuan to 2.8626 billion yuan in 2020.
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.